COMMUNIQUÉ DE PRESSE publié le 26/02/2024 à 14:00, il y a 1 année 9 mois FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM) FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRÈVE publiée le 26/02/2024 à 14:00, il y a 1 année 9 mois FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™ FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
BRÈVE publiée le 26/02/2024 à 14:00, il y a 1 année 9 mois FSD Pharma lance un essai clinique pour tester l'efficacité d'unbuzzd™ FSD Pharma Essai Clinique Unbuzzd™ Métabolisme De L'alcool Sobriété Accélérée
COMMUNIQUÉ DE PRESSE publié le 17/02/2024 à 01:10, il y a 1 année 10 mois FSD Pharma Announces US ATM Offering FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
COMMUNIQUÉ DE PRESSE publié le 06/02/2024 à 13:00, il y a 1 année 10 mois Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
COMMUNIQUÉ DE PRESSE publié le 29/01/2024 à 22:30, il y a 1 année 10 mois FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
COMMUNIQUÉ DE PRESSE publié le 16/01/2024 à 13:30, il y a 1 année 11 mois Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics. Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
COMMUNIQUÉ DE PRESSE publié le 23/12/2023 à 01:45, il y a 1 année 11 mois FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
COMMUNIQUÉ DE PRESSE publié le 05/12/2023 à 15:00, il y a 2 années FSD Pharma Inc. Announces Closing of Private Placement FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
COMMUNIQUÉ DE PRESSE publié le 30/11/2023 à 14:30, il y a 2 années FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities
Publié le 19/12/2025 à 21:57, il y a 1 jour 15 heures Mise à disposition du document d’enregistrement universel
Publié le 19/12/2025 à 08:30, il y a 2 jours 4 heures Share capital decrease by way of treasury shares cancellation
Publié le 19/12/2025 à 08:30, il y a 2 jours 4 heures Réduction du capital par voie d’annulation d’actions propres
Publié le 19/12/2025 à 07:00, il y a 2 jours 6 heures EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Publié le 19/12/2025 à 07:00, il y a 2 jours 6 heures EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Publié le 20/12/2025 à 00:30, il y a 1 jour 12 heures Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Publié le 19/12/2025 à 22:00, il y a 1 jour 15 heures GMV Minerals Inc. Closes Non-Brokered Equity Financing
Publié le 19/12/2025 à 18:30, il y a 1 jour 18 heures Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Publié le 19/12/2025 à 14:40, il y a 1 jour 22 heures Northern Superior Announces Closing of the Arrangement
Publié le 19/12/2025 à 13:30, il y a 1 jour 23 heures Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Publié le 21/12/2025 à 08:55, il y a 4 heures 9 minutes Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Publié le 20/12/2025 à 16:45, il y a 20 heures 19 minutes Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Publié le 20/12/2025 à 10:05, il y a 1 jour 2 heures FITUR 2026 highlights the strong synergies between Germany and Spain
Publié le 19/12/2025 à 22:03, il y a 1 jour 15 heures EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Publié le 19/12/2025 à 21:40, il y a 1 jour 15 heures IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries